By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
An inert powder made of minerals called hemostatic spray doesn’t seem to be absorbed or digested by the gastrointestinal mucosa.
Hemostatic spray coalesces and sticks to the bleeding site when it comes into contact with moisture, creating a mechanical barrier. Scanning electron microscopy was recently used to demonstrate this mechanism.
The majority of experience is with the spray therapy for hemospray, a mineral-based medication that has been widely utilized to reduce gastrointestinal bleeding.
Other treatments are, however, accessible everywhere. The majority of the information on this product’s use comes from Turkey, and research findings suggest that the spray may play a part in regulating gastrointestinal hemorrhage.
The Global Hemostatic Spray market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
New Hemostatic Gauze is Introduced by Omni Stat Medical Inc. A new hemostatic gauze pad has been added to the Omni-stat Medical Inc. product lineup.
The FDA has granted 510k clearance to the OMNI-STAT 2/3in x 4 3/4in hemostatic gauze, which is permitted for use as a temporary topical dressing for bleeding control associated with minor wounds, including control of minor external bleeding and exudate from sutures and/or surgical procedures, when used under the supervision of a healthcare professional.
Additionally, it is suggested for use as an interim external therapy to stop moderate to severe bleeding.
In order to quickly stop bleeding, they developed OMNI-STAT hemostatic gauze, a non-woven gauze pad laminated on both sides with the specialized chitosan granule technology.
